REPLIGEN CORPORATION - COMMON STOCK
146.34
25-11月-24 12:31:48
15 分の遅延
株式
+3.76
+2.63%
本日の幅
142.73 - 148.03
ISIN
N/A
ソース
NASDAQ
-
Repligen Appoints Martin D. Madaus to Board of Directors
09 2 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen to Report Fourth Quarter and Full Year 2022 Financial Results
08 2 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
03 1 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
08 11 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
01 11 2022 07:30:01 提供 Nasdaq GlobeNewswire
-
Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands
01 11 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Repligen to Report Third Quarter 2022 Financial Results
12 10 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement
19 9 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Repligen To Host Investor Day 2022
24 8 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance
02 8 2022 07:30:01 提供 Nasdaq GlobeNewswire
-
Repligen to Report Second Quarter 2022 Financial Results
19 7 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
26 5 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
25 5 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
27 4 2022 07:30:01 提供 Nasdaq GlobeNewswire
-
Repligen to Report First Quarter 2022 Financial Results
13 4 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
18 3 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
17 2 2022 07:30:01 提供 Nasdaq GlobeNewswire
-
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
15 2 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen Corporation to Present at 11th Annual SVB Leerink Healthcare Conference
11 2 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Repligen to Report Fourth Quarter and Full Year 2021 Financial Results
03 2 2022 09:30:09 提供 Nasdaq GlobeNewswire